Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Neurocrine Biosciences patents

Patents where

Current Assignee

Name

Neurocrine Biosciences

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11439629 Methods for the administration of certain VMAT2 inhibitors		Neurocrine Biosciences	Neurocrine Biosciences	United States Patent and Trademark Office	11439629	September 13, 2022
‌ US Patent 11311532 High dosage valbenazine formulation and compositions, methods, and kits related thereto	Patent 11311532 was granted and assigned to Neurocrine Biosciences on April, 2022 by the United States Patent and Trademark Office.	Neurocrine Biosciences	Neurocrine Biosciences	United States Patent and Trademark Office	11311532	April 26, 2022
‌ US Patent 7419983 Gonadotropin-releasing hormone receptor antagonists and methods related thereto	Patent 7419983 was granted and assigned to Neurocrine Biosciences on September, 2008 by the United States Patent and Trademark Office.		Neurocrine Biosciences	United States Patent and Trademark Office	7419983	September 2, 2008
‌ US Patent 10065952 Valbenazine salts and polymorphs thereof	Patent 10065952 was granted and assigned to Neurocrine Biosciences on September, 2018 by the United States Patent and Trademark Office.	Neurocrine Biosciences	Neurocrine Biosciences	United States Patent and Trademark Office	10065952	September 4, 2018
‌ US Patent 9868706 Processes for the preparation of uracil derivatives	Patent 9868706 was granted and assigned to Neurocrine Biosciences on January, 2018 by the United States Patent and Trademark Office.	Neurocrine Biosciences	Neurocrine Biosciences	United States Patent and Trademark Office	9868706	January 16, 2018
‌ US Patent 7176211 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto	Patent 7176211 was granted and assigned to Neurocrine Biosciences on February, 2007 by the United States Patent and Trademark Office.		Neurocrine Biosciences	United States Patent and Trademark Office	7176211	February 13, 2007
‌ US Patent 7056927 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto	Patent 7056927 was granted and assigned to Neurocrine Biosciences on June, 2006 by the United States Patent and Trademark Office.		Neurocrine Biosciences	United States Patent and Trademark Office	7056927	June 6, 2006
‌ US Patent 7459458 Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto	Patent 7459458 was granted and assigned to Neurocrine Biosciences on December, 2008 by the United States Patent and Trademark Office.		Neurocrine Biosciences	United States Patent and Trademark Office	7459458	December 2, 2008
‌ US Patent 10905690 Treatment of congenital adrenal hyperplasia	Patent 10905690 was granted and assigned to Neurocrine Biosciences on February, 2021 by the United States Patent and Trademark Office.	Neurocrine Biosciences	Neurocrine Biosciences	United States Patent and Trademark Office	10905690	February 2, 2021
‌ US Patent 10941159 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto	Patent 10941159 was granted and assigned to Neurocrine Biosciences on March, 2021 by the United States Patent and Trademark Office.	Neurocrine Biosciences	Neurocrine Biosciences	United States Patent and Trademark Office	10941159	March 9, 2021
‌ US Patent 10336769 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto	Patent 10336769 was granted and assigned to Neurocrine Biosciences on July, 2019 by the United States Patent and Trademark Office.	Neurocrine Biosciences	Neurocrine Biosciences	United States Patent and Trademark Office	10336769	July 2, 2019
‌ US Patent 8039627 Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-A]isoquinolin-2-ol compounds and methods relating thereto	Patent 8039627 was granted and assigned to Neurocrine Biosciences on October, 2011 by the United States Patent and Trademark Office.		Neurocrine Biosciences	United States Patent and Trademark Office	8039627	October 18, 2011
‌ US Patent 9422310 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto	Patent 9422310 was granted and assigned to Neurocrine Biosciences on August, 2016 by the United States Patent and Trademark Office.	Neurocrine Biosciences	Neurocrine Biosciences	United States Patent and Trademark Office	9422310	August 23, 2016
‌ US Patent 8084614 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto	Patent 8084614 was granted and assigned to Neurocrine Biosciences on December, 2011 by the United States Patent and Trademark Office.		Neurocrine Biosciences	United States Patent and Trademark Office	8084614	December 27, 2011
‌ US Patent 8481738 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto	Patent 8481738 was granted and assigned to Neurocrine Biosciences on July, 2013 by the United States Patent and Trademark Office.		Neurocrine Biosciences	United States Patent and Trademark Office	8481738	July 9, 2013
‌ US Patent 11459305 Processes for the preparation of uracil derivatives	Patent 11459305 was granted and assigned to Neurocrine Biosciences on October, 2022 by the United States Patent and Trademark Office.	Neurocrine Biosciences	Neurocrine Biosciences	United States Patent and Trademark Office	11459305	October 4, 2022
‌ US Patent 7304069 Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto	Patent 7304069 was granted and assigned to Neurocrine Biosciences on December, 2007 by the United States Patent and Trademark Office.		Neurocrine Biosciences	United States Patent and Trademark Office	7304069	December 4, 2007
‌ US Patent 8765948 Processes for the preparation of uracil derivatives	Patent 8765948 was granted and assigned to Neurocrine Biosciences on July, 2014 by the United States Patent and Trademark Office.		Neurocrine Biosciences	United States Patent and Trademark Office	8765948	July 1, 2014
‌ US Patent 7329669 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto	Patent 7329669 was granted and assigned to Neurocrine Biosciences on February, 2008 by the United States Patent and Trademark Office.		Neurocrine Biosciences	United States Patent and Trademark Office	7329669	February 12, 2008
‌ US Patent 7179815 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto	Patent 7179815 was granted and assigned to Neurocrine Biosciences on February, 2007 by the United States Patent and Trademark Office.		Neurocrine Biosciences	United States Patent and Trademark Office	7179815	February 20, 2007
‌ US Patent 7229995 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto	Patent 7229995 was granted and assigned to Neurocrine Biosciences on June, 2007 by the United States Patent and Trademark Office.		Neurocrine Biosciences	United States Patent and Trademark Office	7229995	June 12, 2007
‌ US Patent 11026939 High dosage valbenazine formulation and compositions, methods, and kits related thereto	Patent 11026939 was granted and assigned to Neurocrine Biosciences on June, 2021 by the United States Patent and Trademark Office.	Neurocrine Biosciences	Neurocrine Biosciences	United States Patent and Trademark Office	11026939	June 8, 2021
‌ US Patent 11026931 Methods for the administration of certain VMAT2 inhibitors	Patent 11026931 was granted and assigned to Neurocrine Biosciences on June, 2021 by the United States Patent and Trademark Office.	Neurocrine Biosciences	Neurocrine Biosciences	United States Patent and Trademark Office	11026931	June 8, 2021
‌ US Patent 10906902 Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1,-a]isoquinolin-2-2-amino-3-methylbutanoate di(4-methylbenzenesulfonate)	Patent 10906902 was granted and assigned to Neurocrine Biosciences on February, 2021 by the United States Patent and Trademark Office.	Neurocrine Biosciences	Neurocrine Biosciences	United States Patent and Trademark Office	10906902	February 2, 2021
‌ US Patent 10993941 Methods for the administration of certain VMAT2 inhibitors	Patent 10993941 was granted and assigned to Neurocrine Biosciences on May, 2021 by the United States Patent and Trademark Office.	Neurocrine Biosciences	Neurocrine Biosciences	United States Patent and Trademark Office	10993941	May 4, 2021

Results per page:

72 results

0 selected

72 results

0 selected